3EE-42258-08303
3 vaccinations
11 coded responses
27 check-ins
11 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 067 / CT
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Moderna
-
2021-03-14
Registered in v-safe
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
- 2021-03-16
- 2021-03-17
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Fair · Nausea, Diarrhea, Rash, not including the immediate area around the injection siteFree text: Have started Mesalamine a few days ago so that should be taken into accountMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-19
- 2021-03-26
- 2021-04-02
-
2021-04-09
Dose 2 — Moderna
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Pyrexia — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Yesterday my fever topped out at 101.4-Today I had no feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-13
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Ran six miles yesterday and six todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-16
- 2021-04-23
-
2021-04-30
Survey response — day 21, dose 2MedDRA: Brain fog, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Brain fog and tired- could be from having ColonoscopyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-14
-
2021-05-21
Survey response — day 42, dose 2MedDRA: Exercise tolerance decreased, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue- used to be able to run 9 miles a day- now only 6MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-10
Survey response — 3 months, dose 2MedDRA: Vertigo — Feeling: Fair · Be unable to do your normal daily activitiesFree text: VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-08
Survey response — 6 months, dose 2MedDRA: Breast cancer, Unevaluable event, Vertigo — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Breast cancer and vertigo · Healthcare visit (other): (b)(6) cancer centerMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-10-23
Dose 3 — Moderna
- 2021-10-30
-
2021-11-06
Survey response — day 14, dose 3MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: After effects of chemotherapyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Survey response — day 21, dose 3MedDRA: Chemotherapy, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue from chemotherapyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-20
Survey response — day 28, dose 3MedDRA: Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Issues from chemotherapyMedDRA releases: 2024-11 · check-in free text available
- 2021-12-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Moderna | |
| 2 | 2021-04-09 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): No
Systemic reaction (other): Have started Mesalamine a few days ago so that should be taken into account
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Yesterday my fever topped out at 101.4-Today I had no fever
Systemic reaction (other): Ran six miles yesterday and six today
Release 8 — day 21, dose 2
Symptoms: Brain fog and tired- could be from having Colonoscopy
Release 8 — day 42, dose 2
Symptoms: Fatigue- used to be able to run 9 miles a day- now only 6
Release 9 — 3 months, dose 2
Symptoms: Vertigo
Release 10 — 6 months, dose 2
Symptoms: Breast cancer and vertigo
Healthcare visit (other): (b)(6) cancer center
redacted (b)(6)
Release 10 — day 14, dose 3
Symptoms: After effects of chemotherapy
Release 10 — day 21, dose 3
Symptoms: Fatigue from chemotherapy
Release 10 — day 28, dose 3
Symptoms: Issues from chemotherapy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Brain fog | ✓ | ✓ | ✓ |
| SD | Breast cancer | · | · | ✓ |
| SD | Chemotherapy | · | · | ✓ |
| SD | Exercise tolerance decreased | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release